BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6273332)

  • 21. Restoration of the LFA-3 adhesion pathway in Burkitt's lymphoma cells using an LFA-3 recombinant vaccinia virus: consequences for T cell recognition.
    Griffin H; Rowe M; Murray R; Brooks J; Rickinson A
    Eur J Immunol; 1992 Jul; 22(7):1741-8. PubMed ID: 1378014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of the APO-1 antigen in Burkitt lymphoma cell lines correlates with a shift towards a lymphoblastoid phenotype.
    Falk MH; Trauth BC; Debatin KM; Klas C; Gregory CD; Rickinson AB; Calender A; Lenoir GM; Ellwart JW; Krammer PH
    Blood; 1992 Jun; 79(12):3300-6. PubMed ID: 1375849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
    Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
    Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-mediated immunosurveillance mechanisms and the pathogenesis of Burkitt's lymphoma.
    Rooney CM; Rickinson AB; Moss DJ; Lenoir GM; Epstein MA
    IARC Sci Publ; 1985; (60):249-64. PubMed ID: 2998992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncogene expression in isogenic, EBV-positive and -negative Burkitt lymphoma cell lines.
    Glazer PM; Summers WC
    Intervirology; 1985; 23(2):82-9. PubMed ID: 2984143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Over-expression of C-myc increases the sensitivity of Epstein-Barr virus immortalized lymphoblastoid cells to non-MHC-restricted cytotoxicity.
    Cuomo L; Zhang QJ; Lombardi L; Torsteinsdottir S; Klein G; Dalla-Favera R; Masucci MG
    Int J Cancer; 1993 Apr; 53(6):1008-12. PubMed ID: 8386135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible DNA-RNA tumor virus interaction in human lymphomas: expression of retroviral proteins in Ramos lymphoma lines is enhanced after conversion with Epstein-Barr virus.
    Lasky RD; Troy FA
    Proc Natl Acad Sci U S A; 1984 Jan; 81(1):33-7. PubMed ID: 6320170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
    Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
    J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lysis of human B-lymphocyte-derived lymphoma/leukemia cells of established cell lines by interferon-activated natural killer (NK) cells.
    Pattengale PK; Gidlund M; Nilsson K; Sundström C; Orn A; Wigzell H
    Int J Cancer; 1981 Oct; 28(4):459-68. PubMed ID: 6171529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Search for the critical characteristics of phenotypically different B cell lines, Burkitt lymphoma cells and lymphoblastoid cell lines, which determine differences in their functional interaction with allogeneic lymphocytes.
    Avila-Cariño J; Torsteinsdottir S; Ehlin-Henriksson B; Masucci MG; Klein E
    Cancer Immunol Immunother; 1991; 34(2):128-32. PubMed ID: 1722139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumorigenicity of EBV-carrying lymphoblastoid cell lines (LCLs): distinctive grading in SCID mice.
    Ramqvist T; Norén L; Iwarsson K; Klein G
    Int J Cancer; 1991 Oct; 49(4):587-91. PubMed ID: 1655664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the BLA antigen, defined by the monoclonal 38.13 antibody, on Burkitt lymphoma lines, lymphoblastoid cell lines, their hybrids and other B-cell lymphomas and leukemias.
    Klein G; Manneborg-Sandlund A; Ehlin-Henriksson B; Godal T; Wiels J; Tursz T
    Int J Cancer; 1983 May; 31(5):535-42. PubMed ID: 6303966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
    Gregory CD; Rowe M; Rickinson AB
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Herpes simplex virus type 1 infection of isogenic Epstein-Barr virus genome-negative and -positive Burkitt's lymphoma-derived cell lines.
    Leinbach SS; Summers WC
    J Virol; 1979 Apr; 30(1):248-54. PubMed ID: 225521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Host cell phenotype-dependent methylation patterns of Epstein-Barr virus DNA.
    Minarovits J; Minarovits-Kormuta S; Ehlin-Henriksson B; Falk K; Klein G; Ernberg I
    J Gen Virol; 1991 Jul; 72 ( Pt 7)():1591-9. PubMed ID: 1649897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines.
    Hui KF; Leung YY; Yeung PL; Middeldorp JM; Chiang AK
    Br J Haematol; 2014 Dec; 167(5):639-50. PubMed ID: 25155625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation of normal lymphocytes with autologous lymphoid cell lines: properties of derived killer cells.
    Svedmyr E; Jondal M; Leibold W
    Scand J Immunol; 1975; 4(7):721-34. PubMed ID: 173017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of the EBV cycle in B-lymphocyte-derived lines is accompanied by increased natural killer (NK) sensitivity and the expression of EBV-related antigen(s) detected by the ADCC reaction.
    Patarroyo M; Blazar B; Pearson G; Klein E; Klein G
    Int J Cancer; 1980 Sep; 26(3):365-71. PubMed ID: 6270007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD40 cross-linking enhances the immunogenicity of Burkitt's-lymphoma cell lines.
    Frisan T; Donati D; Cervenak L; Wilson J; Masucci MG; Bejarano MT
    Int J Cancer; 1999 Dec; 83(6):772-9. PubMed ID: 10597194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.